The latest closing stock price for Entrada Therapeutics as of January 31, 2025 is 13.44.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-439 today, roughly 0 times their original investment - a -17.52% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 21.79, which is 62.1% above the current share price.
The Entrada Therapeutics 52-week low stock price is 11.35, which is 15.6% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 15.49.
An investor who bought $1,000 worth of Entrada Therapeutics stock at the IPO in 2021 would have $-439 today, roughly 0 times their original investment - a -17.52% compound annual growth rate over 3 years.
The all-time high Entrada Therapeutics stock closing price was 35.00 on November 17, 2021.
The Entrada Therapeutics 52-week high stock price is 21.79, which is 62.1% above the current share price.
The Entrada Therapeutics 52-week low stock price is 11.35, which is 15.6% below the current share price.
The average Entrada Therapeutics stock price for the last 52 weeks is 15.49.